Deferred Tax Assets, Valuation Allowance of Replimune Group, Inc. from 31 Mar 2017 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Replimune Group, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Mar 2017 to 31 Mar 2025.
  • Replimune Group, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Mar 2025 was $221,629,000, a 37% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Replimune Group, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $221,629,000 +$59,739,000 +37% 31 Mar 2025 10-K 22 May 2025 2025 FY
Q1 2024 $161,890,000 +$48,001,000 +42% 31 Mar 2024 10-K 22 May 2025 2025 FY
Q1 2023 $113,889,000 +$38,997,000 +52% 31 Mar 2023 10-K 22 May 2025 2025 FY
Q1 2022 $74,892,000 +$34,864,000 +87% 31 Mar 2022 10-K 16 May 2024 2024 FY
Q1 2021 $40,028,000 +$22,699,000 +131% 31 Mar 2021 10-K 18 May 2023 2023 FY
Q1 2020 $17,329,000 +$7,933,000 +84% 31 Mar 2020 10-K 19 May 2022 2022 FY
Q1 2019 $9,396,000 +$4,672,000 +99% 31 Mar 2019 10-K 20 May 2021 2021 FY
Q1 2018 $4,724,000 +$2,837,000 +150% 31 Mar 2018 10-K 03 Jun 2020 2019 FY
Q1 2017 $1,887,000 31 Mar 2017 10-K 28 Jun 2019 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.